Lighthouse Pharmaceuticals
Develops novel small-molecule therapies for neurodegenerative and inflammatory diseases
$12MSeries A
Role not disclosedLoading investors…
Activity from announced rounds
Develops novel small-molecule therapies for neurodegenerative and inflammatory diseases